2024 Q3 Portfolio Activity
In 2024 Q3, RiverVest Venture Management LLC maintained a portfolio of 4 distinct positions. They heavily accumulated shares in Reneo Pharmaceuticals, Inc., increasing the position by 4692.3%.
Position History
hover any row below to update
Loading…
Total Positions
4
Quarter
2024 Q3
Top Holding
N/A (63.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-4 of 4
RiverVest Venture Management LLC Full Holdings List — 2024 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
Reneo Pharmaceu...
|
|
Unknown | 63.00% | 56.07% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
2,534,220 | $4,308,174,000 | — | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | ||
|
SPRB
Spruce Bioscien...
|
Healthcare | 20.39% | 22.27% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
2,936,281 | $1,394,441,000 | 2021 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
XLO
Xilio Therapeut...
|
Healthcare | 16.60% | 20.01% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
1,441,444 | $1,135,425,000 | 2021 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
N/A
Vapotherm, Inc.
|
|
Unknown | 0.00% | 1.65% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-52,881 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) |
Showing 1-4 of 4 holdings